Development and manufacture of supramolecular active ingredient carriers and topical treatments against infections for human and veterinary medicine.
Aalto Pharma AG
Bahnhofstrasse 4, 6340 Baar · Rathaustrasse 14, 6341 BaarNew on Amplifa
About Aalto Pharma
Aalto Pharma AG is a pharmaceutical company founded in 2022 in Baar in the canton of Zug (Switzerland) with Nordic roots. The company develops and produces treatments for topical infections caused by bacteria, viruses and fungi, based on a patented supramolecular delivery platform. At the core of the technology is an intelligent polymeric carrier that transports active ingredients (APIs) in a targeted manner to the infection site. The supramolecular molecules and formulations are manufactured on a production facility that, according to the company, is unique; in addition, the portfolio of services includes its own R&D as well as testing and efficacy verification of the innovations in cooperation with independent research institutes. The solutions are aimed at applications in human and veterinary medicine, including against antibiotic-resistant bacteria such as E. coli, A. baumannii and P. aeruginosa. No meaningful production or component images are available from the website; the images shown depict Swiss landscape motifs and the company logo.
- Site
- Baar
- Processes
- Manufacture of supramolecular molecules and treatments on unique production equipment, R&D and inspection of in-house innovation and efficacy verification, R&D (own R&D facility, cooperation with research institutes), Manufacture of supramolecular active ingredient carriers, Inspection/Testing
- Materials
- Polymeric carrier (supramolecular delivery platform), Silver ion formulations (liquid, topical), Silver ion formulations
- Founded
- 2022
- Employees
- 1–10
- Industries
- Pharma/Biopharma, Medical Technology/Medical Devices, Veterinary/Animal Care, Therapeutics, Veterinary (Animal Care), Human medicine (topical infections)
- 01
R&D (own facility, cooperation with research institutes)
- 02
Manufacture of supramolecular molecules and formulations
- 03
Inspection / Testing (efficacy verification)
- 04
Distribution (international trade)
Materials & Processes
Polymeric carrier (supramolecular delivery platform)
Intelligent polymeric carrier that delivers the active ingredient quantity in a targeted manner to the infection site.
Silver ion formulations
Liquid topical formulations with silver ions for the treatment of infections, including those with antibiotic-resistant bacteria.
Sites
Baar (Bahnhofstrasse 4)
CHHeadquarters
Baar (Rathaustrasse 14)
CHSite with production facility for supramolecular molecules
- Materials
- Polymers (polymeric carrier), active ingredients (APIs), silver ions
- Production facility for supramolecular molecules (unique)
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Manufacture of supramolecular molecules and treatments on unique production equipmentPlastics | – | – | – | – | Polymers (polymeric carrier), Active ingredients (APIs), Silver ions |
| R&D and inspection of in-house innovation and efficacy verificationTesting | – | – | – | – | – |
1 Anlagen & Maschinen
| Machine | Manufacturer / model | Quantity | Working area | Year built | Site |
|---|---|---|---|---|---|
| Production facility for supramolecular molecules (unique system) | – | – | – | – | Baar, Switzerland |
Additional services
History
- 2022
Foundation of Aalto Pharma AG in Baar, canton of Zug (capital 100.000 CHF)